CATANIA, ITALY - NOVEMBER 24: Two cancer patients attend a chemotherapy session in the Medical Oncology department headed by Dr Giusi Scandurra of Cannizzaro hospital on November 24, 2020 in Catania, Italy.
In the Oncology and Senology departments of LONDON - Researchers say a genetically modified herpes virus is showing promise in fighting against a range of advanced cancers in early trial results.A team from The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, said the virus, RP2, proved to be effective in a quarter of patients taking part in the experiment.
They presented their findings at the 2022 European Society for Medical Oncology (ESMO) Congress.RELATED: Sitting less, more physical activity 'highly likely' to lower breast cancer risk, study saysThe patients had various forms of cancer including skin, esophageal, and head and neck.
Researchers said the patients had exhausted other treatments.Researchers said they injected the RP2 virus directly into the cancer tumors.